A few years ago, scientists discovered a vaccine candidate that could halt the spread of the sexually transmitted disease.
Now, researchers are trying to figure out how the vaccine can be administered to a broader range of people, including those who have never had HPV before.
The researchers have developed a vaccine that is similar to the HPV vaccine used in the United States.
But the vaccine is much more precise, and it can be given to as many as 10 million people, says Dr. Michael Smith, an assistant professor at the University of North Carolina School of Medicine and an author of a paper about the vaccine that was published online in the journal Science Translational Medicine.
It has been tested in mice, pigs and monkeys, and is also being tested in humans.
The vaccine is an effective, short-acting, low-cost vaccine that targets the virus that causes HPV.
It is designed to protect against the virus by preventing it from developing into more serious forms of the disease, such as cervical cancer.
The vaccine also targets the genetic material that can trigger the infection.
The goal is to create a vaccine in a few years that will be available to millions of people and to be administered at no cost to the public.
But there are still challenges.
The researchers say they’re not sure exactly how much the vaccine works and what kind of side effects people will have.
To determine how well the vaccine prevents the disease in a population, they’re studying the effectiveness of different doses, how many doses of the vaccine are given and how well they work together.
“This is the first vaccine that we’ve seen to have been effective against a vaccine-like virus that’s been circulating in the human population for over 20 years,” Smith says.
The vaccines are being developed with the help of the National Institutes of Health, which has awarded about $1 billion for the work.
They’re being developed using a vaccine engineered by scientists at the U.S. National Institutes for Health.
The project is being done with funding from the National Cancer Institute, the NIH Office of Scientific and Engineering Research and the National Institute on Aging.
They are funded by the National Science Foundation, the Office of Naval Research, the National Endowment for the Humanities and the Department of Defense.
For more health news, visit NBCNews.com